GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tiziana Life Sciences Ltd (NAS:TLSA) » Definitions » Total Liabilities

Tiziana Life Sciences (Tiziana Life Sciences) Total Liabilities : $6.65 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Tiziana Life Sciences Total Liabilities?

Tiziana Life Sciences's Total Liabilities for the quarter that ended in Dec. 2023 was $6.65 Mil.

Tiziana Life Sciences's quarterly Total Liabilities declined from Dec. 2022 ($6.91 Mil) to Jun. 2023 ($4.12 Mil) but then increased from Jun. 2023 ($4.12 Mil) to Dec. 2023 ($6.65 Mil).

Tiziana Life Sciences's annual Total Liabilities declined from Dec. 2021 ($7.55 Mil) to Dec. 2022 ($6.91 Mil) and declined from Dec. 2022 ($6.91 Mil) to Dec. 2023 ($6.65 Mil).


Tiziana Life Sciences Total Liabilities Historical Data

The historical data trend for Tiziana Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tiziana Life Sciences Total Liabilities Chart

Tiziana Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.85 8.27 7.55 6.91 6.65

Tiziana Life Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.55 5.28 6.91 4.12 6.65

Tiziana Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Tiziana Life Sciences's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.539+(0.109+-1.3877787807814E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=6.65

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=12.184-5.536
=6.65

Tiziana Life Sciences's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.539+(0.109+-1.3877787807814E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=6.65

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=12.184-5.536
=6.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tiziana Life Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Tiziana Life Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Tiziana Life Sciences (Tiziana Life Sciences) Business Description

Traded in Other Exchanges
Address
2 Church Street, Clarendon House, Hamilton, BMU, HM 11
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience.

Tiziana Life Sciences (Tiziana Life Sciences) Headlines

From GuruFocus